InMed Pharmaceuticals Inc. Common Shares (INM)
Stock · NASDAQ · Health Care
$1.38as of 8/28/2026
Price chart
Open in TradingViewActive signals
About INM
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to p…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 13
- Website
- www.inmedpharma.com/
Fundamentals
- 1-day range
- $1.38$1.43
- Market cap
- $4.09M
- P/E (trailing)
- —
- P/E (forward)
- -0.22
- EPS (trailing)
- $-2.88
- Dividend yield
- —
- Beta
- 0.96
- Avg. volume
- 943.6K
- Dividend pay date
- July 6, 2020
How InMed Pharmaceuticals Inc. Common Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Sep 23, 2025 · via SEC EDGAR / Finnhub
InMed Pharmaceuticals Inc. Common Shares Competitors
Chosen by industry and closest market cap.
- INMInMed Pharmaceuticals Inc. Common Shares$1.43▼ 0.35%Market cap $4.09MP/E —$0.575$2.5
- ERNAErnexa Therapeutics Inc. Common Stock$4.57▼ 4.99%Market cap $4.02MP/E —$3.18$71.5
- REVBRevelation Biosciences Inc. Common Stock$1.05▲ 1.94%Market cap $3.99MP/E 0.04$0.875$11.6
- ZSTKZeroStack Corp. Common Stock$5.51▼ 6.29%Market cap $4.21MP/E —$1.32$47
- RDHLRedhill Biopharma Ltd. American Depositary Shares$0.6899▲ 9.51%Market cap $3.95MP/E —$0.57$2.79
- MBIOMustang Bio Inc. Common Stock$0.5375▼ 2.27%Market cap $3.88MP/E —$0.525$1.85
- XRTXXORTX Therapeutics Inc. Common Shares$2.34▼ 4.18%Market cap $3.69MP/E —$2.42$9.85
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| INM InMed Pharmaceuticals Inc. Common Shares | $4.09M | — | $1.43 | ▼ 0.35% | $0.575$2.5 |
| ERNA Ernexa Therapeutics Inc. Common Stock | $4.02M | — | $4.57 | ▼ 4.99% | $3.18$71.5 |
| REVB Revelation Biosciences Inc. Common Stock | $3.99M | 0.04 | $1.05 | ▲ 1.94% | $0.875$11.6 |
| ZSTK ZeroStack Corp. Common Stock | $4.21M | — | $5.51 | ▼ 6.29% | $1.32$47 |
| RDHL Redhill Biopharma Ltd. American Depositary Shares | $3.95M | — | $0.6899 | ▲ 9.51% | $0.57$2.79 |
| MBIO Mustang Bio Inc. Common Stock | $3.88M | — | $0.5375 | ▼ 2.27% | $0.525$1.85 |
| XRTX XORTX Therapeutics Inc. Common Shares | $3.69M | — | $2.34 | ▼ 4.18% | $2.42$9.85 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Vivo Opportunity, LLC · July 16, 2026 · Buy2 @ $1.55
- Vivo Opportunity, LLC · July 16, 2026 · Buy19 @ $1.55
- ADAR1 Capital Management, LLC · July 15, 2026 · Buy1.0K @ $1.56
- Vivo Opportunity, LLC · July 15, 2026 · Buy1.4K @ $1.55
- Vivo Opportunity, LLC · July 15, 2026 · Buy13.8K @ $1.55
- Vivo Opportunity, LLC · July 14, 2026 · Buy493 @ $1.55
- Vivo Opportunity, LLC · July 14, 2026 · Buy4.9K @ $1.55
- Vivo Opportunity, LLC · July 2, 2026 · Buy147 @ $1.55
- Vivo Opportunity, LLC · July 2, 2026 · Buy1.5K @ $1.55
- Vivo Opportunity, LLC · July 1, 2026 · Buy398 @ $1.55
- Vivo Opportunity, LLC · July 1, 2026 · Buy3.9K @ $1.55
- Vivo Opportunity, LLC · June 30, 2026 · Buy55 @ $1.54
- Vivo Opportunity, LLC · June 30, 2026 · Buy545 @ $1.54
- Vivo Opportunity Cayman Fund, L.P. · June 8, 2026 · Buy3.0K @ $1.52
- Vivo Opportunity Cayman Fund, L.P. · June 8, 2026 · Buy29.5K @ $1.52
Institutional Ownership
March 31, 2026
- Total shares held
- 319.3K
- Total value held
- $193.0K
- Institutional holders
- 9
- Unknown220.3K
- Unknown47.0K
- Unknown20.0K
- Unknown18.7K
- Unknown8.1K
- Unknown5.0K
- Unknown300
- Unknown6
- Unknown2
See the full, filterable feed with live charts on the MarketWall dashboard.